Shenzhen Stock Exchange: Supervision letter ( Blue Sail Medical Co.Ltd(002382) )

1. Supervision letter on Blue Sail Medical Co.Ltd(002382) CGH [2022] No. 89 Blue Sail Medical Co.Ltd(002382) board of directors: according to the announcement on the resolution of the 22nd Meeting of the 5th board of directors disclosed by your company on April 13, 2022, your company convened the board of directors to review and approve the plan on profit distribution of the company in 2021, which is planned to take the total share capital registered on the date of equity distribution as the base, Distribute cash dividend of 1.00 yuan (including tax) to all shareholders for every 10 shares. Based on the total share capital of 1007053874 shares of your company as of December 31, 2021, it is proposed to distribute cash dividend of 101 million yuan (including tax). The annual report of your company in 2021 shows that the distributable profit of the parent company at the end of the period is -454 million yuan, and the amount of cash dividend is greater than the amount of distributable profit. As reminded and urged by our department, your company disclosed the announcement on the resolution of the 23rd Meeting of the 5th board of directors on April 21, 2022, which said that your company did not meet the conditions for profit distribution for the time being, and decided to cancel the plan for profit distribution in 2021 originally proposed to be submitted to your company’s 2021 annual general meeting for deliberation. The profit distribution plan in 2021 was changed to no cash dividend, no bonus shares No accumulation fund shall be converted into share capital. Article 6.1.5 and article 1.5.5 of the rules of the board of directors of the Shenzhen Stock Exchange on the deliberation of article 22.1 and article 5.5.5 of the rules of the board of directors on the prudent regulation of the operation of Listed Companies in 2021 were violated. We hope that your company and all directors, supervisors and senior managers will draw lessons and make timely rectification to prevent the recurrence of the above problems. At the same time, remind your company and all directors, supervisors and senior managers to strictly abide by the securities law, the company law and other laws, as well as the stock listing rules and relevant regulations of the exchange, truly, accurately, completely, timely and fairly perform the obligation of information disclosure, and prevent such events. This is to inform the management department of listed companies of Shenzhen Stock Exchange on April 23, 2022